Laboratory testing in disseminated intravascular coagulation

Area of Science:

• Hematology
• Clinical Pathology

Background:

• Disseminated intravascular coagulation (DIC) diagnosis involves clinical assessment, identifying the underlying cause, and laboratory tests.
• Clinical presentation of DIC varies based on the primary condition.
• No single laboratory test can definitively diagnose or exclude DIC.

Purpose of the Study:

• To review the diagnostic approaches for disseminated intravascular coagulation (DIC).
• To highlight the limitations of current diagnostic methods and the potential of emerging tests.

Main Methods:

• Review of clinical and laboratory diagnostic criteria for DIC.
• Evaluation of global hemostasis tests, fibrinolytic markers (D-dimer), natural anticoagulants, and novel diagnostic tools.
• Consideration of specific biomarkers like procalcitonin and activated factor X clotting time in context-dependent scenarios.

Main Results:

• Laboratory diagnosis of DIC necessitates a combination of tests due to the limited diagnostic efficiency of individual assays.
• Normal D-dimer levels are valuable for excluding DIC.
• Decreased natural anticoagulants (antithrombin, protein C) are common but not typically part of standard algorithms.
• Emerging tests like clot waveform analysis and activated factor X clotting time show potential but require further validation or are instrument-specific.

Conclusions:

• The diagnosis of DIC is complex, integrating clinical and laboratory findings.
• A multi-test strategy is essential, with D-dimer playing a key role in ruling out the condition.
• Ongoing research into novel biomarkers and assays may improve the accuracy and specificity of DIC diagnosis in the future.